Faye Janice Lim

Faye Janice Lim

Auto-generated profile, based on publicly available information

Faye Janice Lim

Wesfarmers Centre of Vaccine and Infectious Diseases, Telethon Kids Institute, The University of Western Australia, West Perth, Western Australia, Australia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2016 in Respirology
Verified
Journal Article
Closed access
PDF file
FLFaye Janice Lim
Faye Janice Lim
NKNicholas de Klerk
Nicholas de Klerk
CBChristopher Charles Blyth
Christopher Charles Blyth
PFParveen Fathima
Parveen Fathima
HMHannah Moore
Hannah Moore

23 November 2017 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
PDF file
PFParveen Fathima
Parveen Fathima
CBChristopher Charles Blyth
Christopher Charles Blyth
DLDeborah Lehmann
Deborah Lehmann
FLFaye J Lim
Faye J Lim
TATasnim Abdalla
Tasnim Abdalla
HMHannah Moore
Hannah Moore
Pneumococcal conjugate vaccine (PCV) was included in Australia’s National Immunisation Program for all children from 2005. We assessed the impact of PCV on all-cause and pathogen-specific pneumonia hospitalizations in Western Australian (WA) children aged ≤16 years. All hospitalizations with pneumonia-related International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification diagnosis codes occurring in WA-born children (1996–2012) were linked to pathology records. Age-specific incidence rate ratios and temporal trends for all-cause and pathogen-specific pneumonia hospitalizations were calculated before and after PCV introduction. Among 469589 births, there were 15175 pneumonia-related hospitalizations. Hospitalization rates were 6.7 (95% confidence interval, 6.4–6.9) times higher in Aboriginal than in non-Aboriginal children. Following PCV introduction, all-cause pneumonia hospitalizations showed significant declines across all age groups. A pathogen was identified in 2785 of 6693 (41.6%) pneumonia hospitalizations that linked to a pathology record. Respiratory syncytial virus (RSV) was most frequently identified, with RSV-associated pneumonia hospitalization rates of 89.6/100000 child-years in Aboriginal and 26.6/100000 child-years in non-Aboriginal children. The most common bacterial pathogen was Streptococcus pneumoniae in Aboriginal children (32.9/100000 child-years) and Mycoplasma pneumoniae in non-Aboriginal children (8.4/100000 child-years). Viral pneumonia rates declined in all children following PCV introduction, with the greatest declines seen in non-Aboriginal children; declines in bacterial pneumonia were observed in non-Aboriginal children. Based on our ecological analyses, PCV seems to have had an impact on hospitalizations for pneumonia, suggesting that the pneumococcus is likely to play a role in both bacterial and viral pneumonia. Respiratory viruses remain an important pathogen in childhood pneumonia. Vaccines targeting respiratory viruses are needed to combat the residual burden of childhood pneumonia.

1 October 2017 in Vaccine
Verified
Journal Article
Closed access
AHAlexandra Hogan
Alexandra Hogan
PCPatricia T. Campbell
Patricia T. Campbell
CBChristopher Charles Blyth
Christopher Charles Blyth
FLFaye J. Lim
Faye J. Lim
PFParveen Fathima
Parveen Fathima
KGKathryn Glass
Kathryn Glass

1 September 2016 in Epidemics
Verified
Journal Article
Open access
AHAlexandra Hogan
Alexandra Hogan
RARobert S. Anderssen
Robert S. Anderssen
SDStephanie Davis
Stephanie Davis
HMHannah Moore
Hannah Moore
FLFaye J. Lim
Faye J. Lim
KGKathryn Glass
Kathryn Glass
Respiratory syncytial virus (RSV) causes respiratory illness in young children and is most commonly associated with bronchiolitis. RSV typically occurs as annual or biennial winter epidemics in temperate regions, with less pronounced seasonality in the tropics. We sought to characterise and compare the seasonality of RSV and bronchiolitis in temperate and tropical Western Australia. We examined over 13 years of RSV laboratory identifications and bronchiolitis hospitalisations in children, using an extensive linked dataset from Western Australia. We applied mathematical time series analyses to identify the dominant seasonal cycle, and changes in epidemic size and timing over this period. Both the RSV and bronchiolitis data showed clear winter epidemic peaks in July or August in the southern Western Australia regions, but less identifiable seasonality in the northern regions. Use of complex demodulation proved very effective at comparing disease epidemics. The timing of RSV and bronchiolitis epidemics coincided well, but the size of the epidemics differed, with more consistent peak sizes for bronchiolitis than for RSV. Our results show that bronchiolitis hospitalisations are a reasonable proxy for the timing of RSV detections, but may not fully capture the magnitude of RSV epidemics.

30 October 2017 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
PDF file
FLFaye J. Lim
Faye J. Lim
CBChristopher Charles Blyth
Christopher Charles Blyth
PFParveen Fathima
Parveen Fathima
NKNicholas de Klerk
Nicholas de Klerk
HMHannah Moore
Hannah Moore
Background: Reliance on hospital discharge diagnosis codes alone will likely underestimate the burden of respiratory viruses.Objectives: To describe the epidemiology of respiratory viruses more accurately, we used record linkage to examine data relating to all children hospitalized in Western Australia between 2000 and 2012.Patients/Methods: We extracted hospital, infectious disease notification and laboratory data of a cohort of children born in Western Australia between 1996 and 2012. Laboratory records of respiratory specimens collected within 48 hours of admission were linked to hospitalization records. We calculated the frequency and rates of virus detection. To identify groups where under‐ascertainment for respiratory viruses was greatest, we used logistic regression to determine factors associated with failure to test.Results and conclusions: Nine percentage of 484 992 admissions linked to a laboratory record for respiratory virus testing. While 62% (n = 26 893) of laboratory‐confirmed admissions received respiratory infection diagnosis codes, 38% (n = 16 734) had other diagnoses, notably viral infection of unspecified sites. Of those tested, incidence rates were highest for respiratory syncytial virus (247 per 100 000 child‐years) followed by parainfluenza (63 per 100 000 child‐years). Admissions among older children and those without a respiratory diagnosis were associated with failure to test for respiratory viruses. Linked data can significantly enhance diagnostic codes when estimating the true burden of disease. In contrast to current emphasis on influenza, respiratory syncytial virus and parainfluenza were the most common viral pathogens among hospitalized children. By characterizing those failing to be tested, we can begin to quantify the under‐ascertainment of respiratory viruses.

24 February 2019 in BMJ Open
Verified
Journal Article
Open access
PDF file
RBRosanne Barnes
Rosanne Barnes
CBChristopher C Blyth
Christopher C Blyth
NKNicholas de Klerk
Nicholas de Klerk
WLWei Hao Lee
Wei Hao Lee
MBMeredith L Borland
Meredith L Borland
HMHannah Moore
Hannah Moore
Introduction Studies examining acute respiratory infections (ARIs) in emergency department (EDs), particularly in rural and remote areas, are rare. This study aimed to examine the burden of ARIs among Aboriginal and non-Aboriginal children presenting to Western Australian (WA) EDs from 2002 to 2012. Method Using a retrospective population-based cohort study linking ED records to birth and perinatal records, we examined presentation rates for metropolitan, rural and remote Aboriginal and non-Aboriginal children from 469 589 births. We used ED diagnosis information to categorise presentations into ARI groups and calculated age-specific rates. Negative binomial regression was used to investigate association between risk factors and frequency of ARI presentation. Results Overall, 26% of presentations were for ARIs. For Aboriginal children, the highest rates were for those aged <12 months in the Great Southern (1233 per 1000 child-years) and Pilbara regions (1088 per 1000 child-years). Rates for non-Aboriginal children were highest in children <12 months in the Southwest and Kimberley (400 and 375 per 1000 child-years, respectively). Presentation rates for ARI in children from rural and remote WA significantly increased over time in all age groups <5 years. Risk factors for children presenting to ED with ARI were: male, prematurity, caesarean delivery and residence in the Kimberley region and lower socio-economic areas. Conclusion One in four ED presentations in WA children are for ARIs, representing a significant out-of-hospital burden with some evidence of geographical disparity. Planned linkages with hospital discharge and laboratory detection data will aid in assessing the sensitivity and specificity of ARI diagnoses in ED.